Pulmonary Embolism WArsaw REgistry
Pulmonary Embolism WArsaw REgistry
Initiated in January 2008, The PE-aWARE (Pulmonary Embolism WArsaw REgistry) is an on-going
 single-centre prospective observational study of patients with confirmed acute pulmonary
 embolism (APE). Extensive data on consecutive patients with pulmonary embolism is collected
 and stored. The main objective is to collect and provide information on patients'
 characteristics, management, and outcome with the purpose of decreasing mortality in APE, the
 occurrence of bleeding, and the frequency of thromboembolic recurrences. Moreover, the
 PE-aWARE registry serves as a basis for creating predictive scores for clinicians which aid
 patient management. The study endpoints comprise clinically recognized (and objectively
 confirmed) recurrences of PE, major and minor bleeding complications classified according to
 the International Society on Thrombosis and Haemostasis classification, need for
 cardiopulmonary resuscitation or catecholamines, and death.
The Pulmonary Embolism WArsaw REgistry (PE-aWARE) is an on-going prospective observational
 study of patients with confirmed acute pulmonary embolism (APE). Carried out since January
 2008, the registry includes consecutive patients hospitalized at a single centre. The primary
 data recorded include details of each patient's clinical status, co-morbidities, the
 prescribed treatment, the results of additional studies (ie EKG, imaging studies), and the
 outcome. The study endpoints comprise clinically recognized (and objectively confirmed)
 recurrences of PE, major and minor bleeding complications classified according to the
 International Society on Thrombosis and Haemostasis classification, need for cardiopulmonary
 resuscitation or catecholamines, and death.

 Collecting the fore mentioned data allows for clinicians to better manage the diagnostic
 workup and treatment and thus facilitates the prevention of possible future complications in
 APE patients.
Inclusion Criteria:

 -  objectively confirmed pulmonary embolism

 -  Informed consent for the participation in the study, according to the requirements of
 the ethics committee

 Exclusion Criteria:

 -  lack of consent